Skip to main content
. 2020 Dec 19;9(12):929. doi: 10.3390/antibiotics9120929

Table 4.

ACSS sum scores of (i) typical symptoms in relation to amount of bacteriuria, (ii) differential symptoms, and (iii) quality of life derived from the same patients of the US group at Day 1 (Diagnostics) and Day 5/6 (End of Therapy). p-paired t-test.

Day 1 (Diagnostics) Day 5/6 (End of Therapy)
ACSS Patients Sum Score Patients Sum Score
Domain N
(total)
Mean
(SD)
Median
(IQR)
N
(total)
Mean
(SD)
Median
(IQR)
p-value
Typical Total 100 10.49
(2.60)
10
(9;12)
100 0.98
(1.94)
0
(0;1)
<0.001
<104 CFU/mL
43 10.53
(2.59)
11
(9;12.5)
43 1.49
(2.60)
0
(0;2)
<0.001
104 CFU/mL
29 10.66
(2.93)
11
(9;13)
29 0.48
(1.12)
0
(0:0)
<0.001
>105 CFU/mL
28 10.25
(2.29)
10
(9;12)
28 0.71
(1.12)
0
(0;1.3)
<0.001
Differential 100 1.57
(1.74)
1
(0;3)
100 0.34
(0.62)
0
(0;1)
<0.001
QoL 100 5.48
(2.46)
6
(4;7)
100 0.46
(0.93)
0
(0;0)
<0.001
ACSS total 100 17.54
(5.30)
17
(14;22)
100 1.78
(2.82)
0
(0;2)
<0.001